Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I
β Scribed by G. Fabbnni; M. M. Mouradian; J. L. Junecos; J. Schlegel; E. Mohr; Dr. T. N. Chase
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 664 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Loss of dopamine neurons in Parkinson's disease (PD) initiates a complex stream of effects that results in the development of tremor, bradykinesia, and rigidity. While levodopa remains the most effective drug for the symptomatic treatment of PD, its chronic administration is associated with the deve
We read with interest the abstract by Olson et al. (I). They showed that gabapentin improves rigidity, bradykinesia, and tremor in parkinsonism and Parkinson's disease (PD). We administered gabapentin, 900 mg per day, in an open trial to seven nondemented patients with PD who had painful dystonia,
In questioning the diagnosis of a What is it? case (l), Quinn and Hardie (2) state that in their experience linear streaks of increased signal in the putamen on magnetic resonance imaging (MRI) are not seen in Huntington's disease but were seen in four of their cases of neuroacanthocytosis (3). In t